Sign Out
Pregnancy category C. The safety of rebamipide in pregnant women has not been established. Thus, this drug should only be used in pregnant women if the potential benefit outweighs any potential risk.
Pre-clinical studies have shown that rebamipide is distributed into breast milk; thus, rebamipide is not recommended for use in breastfeeding women. If this medicine must be used, then breastfeeding should be discontinued.
